Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-415-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Bioaccumulation: aquatic / sediment
Administrative data
Link to relevant study record(s)
Description of key information
The analogue substance is not bioaccumulative.
Key value for chemical safety assessment
- BCF (aquatic species):
- 77.7 L/kg ww
Additional information
In accordance with column 2 of EC 1907/2006 Annex IX bioaccumulation testing in aquatic species is not required if the substance has a low potential for bioaccumulation. Due to the chemical properties of the test substance the potential for bioaccumulation is assumed to be low.
There is no specific data on the substance. Read-across to the properties of Hexanoic acid, 3,5,5-trimethyl-, 1,1'-[2-ethyl-2-[[(3,5,5-trimethyl-1-oxohexyl)oxy]methyl]-1,3-propanediyl] ester (EC 613-848-7, CAS65870-94-2),Fatty acid polyols (Fatty acids, C5-9, esters with pentaerythritol (EC 270-290-3, CAS 68424-30-6) and Decanoic acid, ester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol octanoate (EC 234-392-1, CAS 11138-60-6)) and their analogues is applicable based on the similarity in structure and physico-chemical properties.
The justification for read-across is presented in Section 13 Assessment reports- Read-across justification.
The log Kow for EC 613-848-7 was experimentally determined to be > 9.4 . For log Kow values between 1 and 6, the BCF increases linearly. At very high log Kow (> 6), a decreasing relationship between the two parameters is observed. Moreover, the experimental and QSAR-based determination of the BCF is inaccurate or even technically not feasible for poorly water soluble substances like EC 613-848-7. For substances with a log Kow of > 10 the BCF is probably lower than 2000 L/kg which indicates that the test substance is not bioaccumulative according to the PBT-criteria (according to “Guidance on information requirements and chemical safety assessment – Chapter R.11: PBT Assessment” published by ECHA (2008)). A BCF was calculated to be 77.7 L/kg wet weight (BCFBAF v3.00, regression based estimate) which correlates with the assumptions from the ECHA Guidance.
Furthermore, a log Kow of ≥ 10 can be taken as an indicator for reduced bioaccumulation potential (according to “Guidance on information requirements and chemical safety assessment – Chapter R.7c: Endpoint specific guidance” published by ECHA (2008). As the Log Kow of the test substance has been experimentally determined to be > 9.4 the substance is not expected to be bioaccumulative.
In addition, the test substance is poorly soluble in water (< 2.4 mg/L) so only low concentrations can be expected in the aquatic environment and thus in aquatic organisms. Furthermore the test substance is readily biodegradable. If the test substance is occasionally released to the aquatic environment it will be readily biodegraded, which reduces the potential uptake by aquatic organisms.
Acute studies with aquatic organisms on structural analogue substances did not result in any toxic effects in the range of water solubility.
The justification for read-across is presented in Section 13 Assessment reports- Read-across justification.
Chronic toxicity data with mammals exhibited no toxic effects to rats after 28- days of exposure for the read-across substance Fatty acids, C5-10, esters with pentaerythritol (CAS 68424-31-7). This is an indication that the test substance is chronically non-toxic.
Although there are no quantitative data on the uptake of Fatty Acid Polyol Esters they might be absorbed via oral, respiratory, and dermal routes of exposure. The absorbability of esterified alcohols containing one to eight ester groups given orally has been studied and there was little difference for polyol esters up to four ester groups. Esters of polyols (pentaerythritol, dipentaerythritol and 1,1,1-trimethylolpropane) have a common metabolic fate that involves stepwise hydrolysis to the carboxylic (e.g. fatty) acids and their polyols (pentaerythritol, dipentaerythritol or trimethylolpropane), respectively. This is supported by the action of ubiquitously distributed unspecific esterases and by site-specific and non-specific gastrointestinal lipases so only low and transient exposure to the parent compound is expected.
Straight-chain fatty acids are normal dietary constituents and ubiquitous substrates for energy production by physiological pathways like the citric acid cycle, sugar synthesis, and lipid synthesis. Medium-chain fatty acids (MCFA) are readily absorbed from the small intestine directly into the bloodstream and transported to the liver for hepatic metabolism, while long-chain fatty acids (LCFA) are less readily absorbed, are incorporated into chylomicrons and enter the lymphatic system. It has been noted by several investigators that increasing fatty acid chain length slightly decreased their digestibility. MCFA are readily broken down to carbon dioxide and two-carbon fragments, while LCFA are re-esterified to triacylglycerols and either metabolized for energy or stored in adipose tissue. Fatty acids are therefore inherently harmless.
The polyols are very polar (log Kow<-2) and do not accumulate in the body but are readily excreted via urine. Alternatively, one or several hydroxyl groups can be oxidized to a carboxylic acid moiety prior to urinary excretion. In conclusion there are sufficient toxicity data for both the resulting fatty acids and the alcohol component, showing that the metabolites have little or no potential to cause toxic effects.
Thus, in view of the harmlessness of degradation products and that no bioaccumulation in animal tissue is expected, further testing is not necessary.
Therefore, in accordance with Annex XIII the substance is not bioaccumulative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.